Streetbeat News

Products Services

STLA

Stellantis NV (NYSE:STLA) faced production issues with its electric 500e model in Italy due to delayed government EV incentives, leading to fewer units produced than planned. Despite this, Stellantis' overall vehicle production in Italy increased by 9.6% last year. The Italian government's new plans to support EV purchases with €930 million may boost future sales. STLA shares saw a slight increase of 0.92% to $22.42.

Portfolio Pulse from Shivani Kumaresan

January 05, 2024 | 5:23 pm

APLT

Applied Therapeutics' stock trades lower following the announcement of topline results from its ARISE-HF Phase 3 trial of AT-001 in Diabetic Cardiomyopathy, which suggests the results may not have met investor expectations.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:20 pm

LLY

MRK

MRNA

PFE

STZ

TAP

VYM

The article discusses the financial benefits of participating in Dry January, where people abstain from alcohol, saving money that could be invested. It mentions the Vanguard High Dividend Yield ETF (VYM) as a comparable U.S. investment to a U.K. dividend yield ISA. It also highlights healthcare stocks like Eli Lilly (LLY), Pfizer (PFE), Moderna (MRNA), and Merck & Company (MRK) as potential investments, with LLY making gains from weight-loss treatments and PFE close to releasing a similar product. Alcohol company stocks like Molson Coors (TAP) and Constellation Brands (STZ) have also seen increases in the first week of January.

Portfolio Pulse from Neil Dennis

January 05, 2024 | 5:20 pm

ILMN

JNJ

Illumina, Inc. (NASDAQ:ILMN) has entered into a collaboration with Janssen Research & Development, a Johnson & Johnson (NYSE:JNJ) unit, to develop a novel molecular residual disease (MRD) assay for cancer testing. This whole-genome sequencing (WGS) multi-cancer research solution aims to detect circulating tumor DNA (ctDNA) and improve the standard of care by providing more accurate responses to treatment. The WGS MRD assay is currently in development and is expected to offer a cost-effective, highly sensitive, and automated workflow with a quick turnaround time. Illumina's stock (ILMN) saw a slight increase of 0.73% to $132.38.

Portfolio Pulse from Nabaparna Bhattacharya

January 05, 2024 | 5:01 pm

ALLO

Allogene Therapeutics' stock price has declined following the announcement of its 2024 platform vision for the future of CAR T. Additionally, the stock received downgrades from JMP Securities and Guggenheim, which likely contributed to the negative sentiment.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:43 pm

HMC

TSLA

VWAGY

A group of 33 U.S. senators has urged Tesla (NASDAQ:TSLA) and 12 other automakers to remain neutral in unionization efforts by the United Auto Workers (UAW). The senators, including high-profile Democrats, emphasized the importance of neutrality, especially as these companies benefit from federal funds for electric vehicle transition. The letter cites NLRB findings of Tesla's illegal tactics against unionizing. Additionally, Tesla is conducting a recall of 1.62 million vehicles in China and has adjusted the range estimates for Model S, X, and Y on its website.

Portfolio Pulse from Nabaparna Bhattacharya

January 05, 2024 | 4:41 pm

HMC

SPY

STLA

The U.S. EPA is set to hold a hearing on California's proposal to cease sales of gasoline-only vehicles by 2035. This move aligns with broader efforts to reduce carbon emissions and could impact automakers' strategies.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:30 pm

STNE

StoneCo Ltd. has received the 'Financeira' License from the Brazilian Central Bank, allowing it to offer new financial products like time deposits through its subsidiaries. This license is expected to enhance and diversify StoneCo's funding sources.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:23 pm

IMCR

Immunocore Holdings' stock is trading lower following the company's announcement of strategic priorities and pipeline expansion. The news indicates a shift in focus or strategy, which may cause uncertainty among investors about the company's future direction and the implications for its financial performance.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:16 pm

HSAI

Hesai Technology (NASDAQ:HSAI), a lidar technology company, has secured a contract to supply its AT128 long-range lidar sensors for a new flagship electric vehicle model from a global OEM. The sensors will be integrated into the vehicle's Advanced Driver Assistance Systems (ADAS). Hesai plans to disclose more details in the future. The company has already won contracts for over 50 ADAS series production EV models from 15 major OEMs and Tier-1 suppliers. HSAI's stock price rose by 3.09% to $8.18 following the announcement.

Portfolio Pulse from Shivani Kumaresan

January 05, 2024 | 4:07 pm